Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000437257

Medchemexpress LLC Almonertinib mesylate | 2134096-06-1 | 99.67% | 621.75 | 100 MG
SDP

Catalog No. 5000437257
Encompass_Preferred

Almonertinib mesylate (HS-10296) is an orally available, irreversible, third-generation EGFR tyrosine kinase inhibitor. It exhibits high selectivity for EGFR-sensitizing and T790M resistance mutations, showing significant inhibitory activity against T790M, T790M/L858R, and T790M/Del19 mutations while being less effective against wild-type EGFR. It is primarily used in research for non-small cell lung cancer and can also inhibit other EGFR sensitive mutations.

  • Orally available, irreversible EGFR tyrosine kinase inhibitor
  • High selectivity for EGFR-sensitizing and T790M resistance mutations
  • Significant inhibitory activity against various T790M mutations
  • Less effective against wild-type EGFR
  • Used in research for non-small cell lung cancer
  • Inhibits other EGFR sensitive mutations including G719X, del19, L858R, and L861Q

Catalog No. 50-004-37257 Supplier Medchemexpress LLC Supplier No. HY112823A100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Almonertinib mesylate (HS-10296) is an orally available, irreversible, third-generation EGFR tyrosine kinase inhibitor. It exhibits high selectivity for EGFR-sensitizing and T790M resistance mutations, showing significant inhibitory activity against T790M, T790M/L858R, and T790M/Del19 mutations while being less effective against wild-type EGFR. It is primarily used in research for non-small cell lung cancer and can also inhibit other EGFR sensitive mutations.

  • Orally available, irreversible EGFR tyrosine kinase inhibitor
  • High selectivity for EGFR-sensitizing and T790M resistance mutations
  • Significant inhibitory activity against various T790M mutations
  • Less effective against wild-type EGFR
  • Used in research for non-small cell lung cancer
  • Inhibits other EGFR sensitive mutations including G719X, del19, L858R, and L861Q

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.